ATE222775T1 - Glycolipid-komplexe und ihre anwendung. - Google Patents

Glycolipid-komplexe und ihre anwendung.

Info

Publication number
ATE222775T1
ATE222775T1 AT97923373T AT97923373T ATE222775T1 AT E222775 T1 ATE222775 T1 AT E222775T1 AT 97923373 T AT97923373 T AT 97923373T AT 97923373 T AT97923373 T AT 97923373T AT E222775 T1 ATE222775 T1 AT E222775T1
Authority
AT
Austria
Prior art keywords
glycolipid
application
complex
diagnostic methods
glycolipid complexes
Prior art date
Application number
AT97923373T
Other languages
English (en)
Inventor
Karsten Buschard
Pam Fredman
Jan-Eric Mansson
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Application granted granted Critical
Publication of ATE222775T1 publication Critical patent/ATE222775T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT97923373T 1996-05-13 1997-05-10 Glycolipid-komplexe und ihre anwendung. ATE222775T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses
PCT/SE1997/000769 WO1997042974A1 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses

Publications (1)

Publication Number Publication Date
ATE222775T1 true ATE222775T1 (de) 2002-09-15

Family

ID=20402548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923373T ATE222775T1 (de) 1996-05-13 1997-05-10 Glycolipid-komplexe und ihre anwendung.

Country Status (12)

Country Link
US (2) US6352831B1 (de)
EP (1) EP0928201B1 (de)
JP (1) JP2000513332A (de)
AT (1) ATE222775T1 (de)
AU (1) AU728141B2 (de)
CA (1) CA2253883A1 (de)
DE (1) DE69715014T2 (de)
DK (1) DK0928201T3 (de)
ES (1) ES2183177T3 (de)
PT (1) PT928201E (de)
SE (1) SE9601817D0 (de)
WO (1) WO1997042974A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2316041A1 (en) * 1997-12-30 1999-07-08 Pam Fredman Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US6824999B1 (en) * 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6599756B1 (en) * 2000-07-27 2003-07-29 Athena Diagnostics, Inc. Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
EP1940418B1 (de) * 2005-09-29 2011-01-19 Torrey Pines Institute For Molecular Studies Sulfatide zur behandlung von autoimmunkrankheiten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS628055A (ja) 1985-07-05 1987-01-16 Shinotesuto Kenkyusho:Kk 酵素免疫測定方法
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
CA2150956A1 (en) * 1992-12-10 1994-06-23 Robert G. L. Shorr Glycolipid enzyme-polymer conjugates

Also Published As

Publication number Publication date
CA2253883A1 (en) 1997-11-20
US6352831B1 (en) 2002-03-05
HK1021321A1 (en) 2000-06-09
EP0928201A1 (de) 1999-07-14
US20020034769A1 (en) 2002-03-21
DK0928201T3 (da) 2002-12-23
JP2000513332A (ja) 2000-10-10
PT928201E (pt) 2003-01-31
AU728141B2 (en) 2001-01-04
ES2183177T3 (es) 2003-03-16
AU2918897A (en) 1997-12-05
DE69715014D1 (de) 2002-10-02
WO1997042974A1 (en) 1997-11-20
EP0928201B1 (de) 2002-08-28
SE9601817D0 (sv) 1996-05-13
DE69715014T2 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
TR199701547T1 (xx) Polisakarit antijen protein e�leni�i i�eren a��.
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
EP0643131A3 (de) Vorrichtung zum Sammeln und in-vitro-Transport von Proben, insbesondere für Diagnoseverwendungen.
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
DE69128152D1 (de) Synthetische peptide von menschlichen papillomaviren 1, 6, 11, 16, 18, 31, 33 und 56, die nützlich in immunoassays für diagnostische zwecke sind
KR910005862A (ko) 신규 친수성 유도체, 진단 또는 치료시 그의 응용 그를 함유하는 진단 또는 치료용 키트 및 면역 시약
SE8502574L (sv) Forfarande for tverbindning av en poros polysackaridgel
DE69004260D1 (de) Filtervorrichtung, insbesondere für die ansaugluft von brennkraftmaschinen.
DE69715014D1 (de) Glycolipid-komplexe und ihre anwendung.
EP0683822A4 (de) Herstellung von photoprotein konjugaten und verfahren zu ihrer verwendung.
SE8300320D0 (sv) Monoclonal antibody formulation for diagnostic use
FI894804A0 (fi) Anvaendning av zink- och jaernhydroxid som adjuvanter av antigenloesningar och pao detta saett effektiverade antigenloesningar.
ATE17403T1 (de) Anti-streptolysin o-latex-reagenz und verfahren zu seiner herstellung.
EP0389301A3 (de) Reagenzkomplex für Immunoessay
NL7703877A (nl) Immuno-onderzoek voor de bepaling van catechol- aminen, alsmede voor de uitvoering van een dergelijk onderzoek bruikbare antigenen en antilichamen.
DE69022795D1 (de) Nachweis eines Antikörpers und dessen Immunglobulin-Klasse.
CA2075695A1 (en) Monoclonal antibodies to sulfonated polymers
IE40645B1 (en) Visual method for the detection of syphilis and other treponemal diseases, and an antigen preparation useful therein
DK398086D0 (da) Fremgangsmaade til foroegelse af oploeseligheden af immunokonjugatpraeparationer eller ukonjugeret immunoglobulin samt fremgangsmaade til nedsaettelse af intakte toksinkonjugaters toksicitet
AU647449B2 (en) Method for the immunological determination of ligands
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
DE69006563D1 (de) Befeuchtigungsvorrichtung für Gegenstände, als Teil einer Einrichtung und ihre Anwendung.
KR860008779A (ko) 항체 형성 화합물의 제조방법
AU573748B2 (en) Monoclonal antibody to cancer procoagulant and immunoassay
Shibata et al. Detecting reagent for antiplatelet antibody

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0928201

Country of ref document: EP

REN Ceased due to non-payment of the annual fee